MedTrace Logo

Measurement of Different Anti-Müllerian Hormone Isoforms in Expected Poor Responders

NCT03826888 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2022-08-08

No results posted yet for this study

Summary

This study wants to evaluate significant clinical impact of different AMH isoforms in serum can be present or absent in expected poor responder participants. The specific AMH isoforms could therefore be measured in expected poor responder participants in order to obtain a more realistic clinical picture and therefore be able to give proper information to the participants and selection of medication dose for ovarian stimulation.

Conditions

  • Anti-Mullerian Hormone Isoforms

Sponsors & Collaborators

  • ART Fertility Clinics LLC

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-25
Primary Completion
2021-12-23
Completion
2022-05-30

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03826888 on ClinicalTrials.gov